|
US5925375A
(en)
|
1987-05-22 |
1999-07-20 |
The Liposome Company, Inc. |
Therapeutic use of multilamellar liposomal prostaglandin formulations
|
|
AU617678B2
(en)
|
1987-05-22 |
1991-12-05 |
Liposome Company, Inc., The |
Prostaglandin-lipid formulations
|
|
US4938965A
(en)
|
1987-07-22 |
1990-07-03 |
Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government |
Ocular delivery of prophylactic agents
|
|
SE8703854D0
(sv)
|
1987-10-07 |
1987-10-07 |
Pharmacia Ab |
Prostaglandinderivat for behandling av glaukom eller okuler hypertension
|
|
JP2602964B2
(ja)
|
1989-10-16 |
1997-04-23 |
裕 水島 |
プロスタグランジン類縁体およびその脂肪乳剤
|
|
US5478819A
(en)
|
1993-06-23 |
1995-12-26 |
Simo Tarpila |
Phospholipid composition and use thereof
|
|
US6773719B2
(en)
|
1994-03-04 |
2004-08-10 |
Esperion Luv Development, Inc. |
Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias
|
|
US20010006648A1
(en)
|
1996-02-26 |
2001-07-05 |
Hitoshi Yamauchi |
Liposomes and liposomal dispersion
|
|
US6015716A
(en)
*
|
1996-07-12 |
2000-01-18 |
The Liposome Company, Inc. |
Detection of endotoxin levels in liposomes, lipid bilayers and lipid complexes
|
|
US5997899A
(en)
|
1996-10-01 |
1999-12-07 |
Skyepharma Inc. |
Method for producing liposomes with increased percent of compound encapsulated
|
|
AU6793598A
(en)
|
1997-03-31 |
1998-10-22 |
University Of Iowa Research Foundation, The |
Glycosylceramide-containing liposomes
|
|
EP1115406A4
(fr)
|
1998-09-25 |
2003-03-05 |
Alcon Lab Inc |
Composition ophtalmique agreable, a liberation prolongee, et procede de therapie oculaire
|
|
WO2003030818A2
(fr)
|
2001-10-05 |
2003-04-17 |
Pichit Suvanprakorn |
Principes actifs vehicules par des perles de liposomes
|
|
JP2006502700A
(ja)
|
2002-03-27 |
2006-01-26 |
セラテクノロジーズ、インコーポレイテッド |
高眼内圧および関連症状の予防および治療のための方法および化合物
|
|
ES2294361T3
(es)
|
2002-08-23 |
2008-04-01 |
Santen Pharmaceutical Co., Ltd. |
Colirios estables que contienen latanoprost como principio activo.
|
|
US20040224010A1
(en)
*
|
2002-11-15 |
2004-11-11 |
Optime Therapeutics, Inc. |
Ophthalmic liposome compositions and uses thereof
|
|
EP1567198A4
(fr)
|
2002-12-02 |
2006-05-31 |
Genvec Inc |
Procedes et materiaux destines a traiter des troubles oculaires
|
|
US20040137068A1
(en)
|
2002-12-20 |
2004-07-15 |
Rajiv Bhushan |
Ophthalmic formulation for the prevention and treatment of adverse ocular conditions, particularly those associated with the aging eye
|
|
WO2005000266A2
(fr)
|
2003-05-22 |
2005-01-06 |
Neopharm, Inc. |
Formulations liposomales combinees
|
|
CA2467410A1
(fr)
|
2003-05-27 |
2004-11-27 |
Synphora Ab |
Methode de traitement du glaucome et de l'hypertension oculaire a l'aide d'analogues de la prostaglandine et sans effet secondaire comme la pigmentation
|
|
BRPI0414868A
(pt)
|
2003-10-03 |
2006-11-28 |
Allergan Inc |
composições e métodos compreendendo compostos relacionados com prostaglandina e peptìdios da famìlia do fator trifoliado para o tratamento de glaucoma com hiperemia reduzida
|
|
WO2005094790A1
(fr)
|
2004-04-02 |
2005-10-13 |
Italfarmaco, S.A. |
Formulations liposomales
|
|
US8722097B2
(en)
*
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
|
PL1759702T3
(pl)
|
2004-05-26 |
2009-06-30 |
Bayardo Arturo Jimenez |
Sposób wytwarzania roztworu latanoprostu do oczu oraz roztwór otrzymany tym sposobem
|
|
US8236292B2
(en)
|
2004-06-04 |
2012-08-07 |
Camurus Ab |
Liquid depot formulations
|
|
PT1781787T
(pt)
|
2004-08-23 |
2017-07-17 |
Sylentis Sau |
Tratamento de distúrbios oculares caracterizados por uma pressão intraocular elevada por meio de arnsis
|
|
MX2007002557A
(es)
*
|
2004-09-03 |
2007-10-10 |
Creabilis Therapeutics Spa |
Uso de polipeptidos obtenidos a traves de mutaciones sistematicas de aminoacidos unicos de bloque-a humano y no humano de hmgb1 para prevenir y/o antagonizar las patologias inducidas por hmgb1.
|
|
ES2572811T3
(es)
|
2004-09-09 |
2016-06-02 |
Yeda Research And Development Co., Ltd. |
Mezclas de polipéptidos, composiciones que las contienen y procedimientos para obtener los mismos, y usos de los mismos
|
|
EP1655021B1
(fr)
|
2004-11-09 |
2008-10-29 |
Novagali Pharma SA |
Emulsion huile-dans-eau à basse concentration de l'agent cationique et au potentiel de zéta positif
|
|
US20060188481A1
(en)
|
2005-02-22 |
2006-08-24 |
Saitama Medical School |
Methods for prophylactically or therapeutically treating an animal for an ocular-related disorder
|
|
US7851504B2
(en)
|
2005-03-16 |
2010-12-14 |
Allergan, Inc. |
Enhanced bimatoprost ophthalmic solution
|
|
DK1864666T3
(da)
|
2005-03-31 |
2012-10-29 |
Asahi Glass Co Ltd |
Beskyttelsesmiddel til en retinal neuronal celle indeholdende prostaglandin-F2-alfa-derivat som aktiv ingrediens
|
|
US20070026061A1
(en)
|
2005-05-25 |
2007-02-01 |
Nahid Ali |
Liposomal formulation and use thereof
|
|
US9539202B2
(en)
|
2006-04-28 |
2017-01-10 |
Universidad Complutense De Madrid |
Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
|
|
WO2008120249A1
(fr)
|
2007-03-30 |
2008-10-09 |
Sifi S.P.A. |
Produits pharmaceutiques à base de lipides polaires et non polaires pour utilisation ophtalmique
|
|
CN101049504B
(zh)
*
|
2007-04-05 |
2010-05-19 |
广州立恩生物科技有限公司 |
一种脂质体药物载体及其制备方法
|
|
EP1985298A1
(fr)
|
2007-04-24 |
2008-10-29 |
Azad Pharma AG |
Émulsions ophtalmiques eau dans l'huile contenant des prostaglandines
|
|
US10105441B2
(en)
|
2007-08-16 |
2018-10-23 |
The Schepens Eye Research Institute, Inc. |
Method for inhibiting or reducing dry eye disease by IL-1Ra
|
|
IL186598A0
(en)
*
|
2007-10-11 |
2008-11-03 |
Mohammad Abdulrazik |
Composition and method for the treatment or prevention of glaucoma and ocular hypertension
|
|
CN101888839B
(zh)
|
2007-10-12 |
2013-03-20 |
雷索维克斯药品公司 |
治疗眼睛病症的omega-3脂肪酸、羟基多不饱和脂肪酸、脂氧素类化合物或脂氧化物类化合物
|
|
JP5514098B2
(ja)
|
2008-02-29 |
2014-06-04 |
公益財団法人名古屋産業科学研究所 |
後眼部到達用リポソーム及び後眼部疾患用医薬組成物
|
|
ITRM20080182A1
(it)
|
2008-04-07 |
2009-10-08 |
Medivis S R L |
Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma.
|
|
CA2722971C
(fr)
|
2008-05-09 |
2019-05-07 |
Qlt Plug Delivery, Inc. |
Administration d'agents actifs a liberation prolongee pour traiter le glaucome et l'hypertension oculaire
|
|
EP2127638A1
(fr)
|
2008-05-30 |
2009-12-02 |
Santen Pharmaceutical Co., Ltd |
Procédé et composition pour traiter l'hypertension oculaire et le glaucome
|
|
CN102105118A
(zh)
|
2008-06-24 |
2011-06-22 |
Qlt栓塞输送公司 |
青光眼的联合治疗
|
|
US20100104654A1
(en)
|
2008-10-27 |
2010-04-29 |
Allergan, Inc. |
Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
|
|
US20100209477A1
(en)
|
2009-01-23 |
2010-08-19 |
Qlt Plug Delivery Inc. |
Sustained release delivery of one or more agents
|
|
EP2396070A4
(fr)
|
2009-02-12 |
2012-09-19 |
Incept Llc |
Délivrance de médicament par bouchons d'hydrogels
|
|
US20100247606A1
(en)
|
2009-03-25 |
2010-09-30 |
Allergan, Inc. |
Intraocular sustained release drug delivery systems and methods for treating ocular conditions
|
|
US8470784B2
(en)
|
2009-08-24 |
2013-06-25 |
Stealth Peptides International, Inc. |
Methods and compositions for preventing or treating ophthalmic conditions
|
|
JPWO2011034192A1
(ja)
|
2009-09-17 |
2013-02-14 |
千寿製薬株式会社 |
ラタノプロストを含有する水性点眼剤、並びにラタノプロストの樹脂への吸着の抑制方法
|
|
US20110070294A1
(en)
|
2009-09-23 |
2011-03-24 |
Javeri Indu |
Methods for the Administration of Drugs Using Liposomes
|
|
ES2752008T3
(es)
|
2009-10-30 |
2020-04-02 |
Intratus Inc |
Métodos y composiciones para la liberación sostenida de fármacos
|
|
WO2011098578A2
(fr)
|
2010-02-12 |
2011-08-18 |
Bioneer A/S |
Système de liposomes pour administration oculaire
|
|
CA2791278C
(fr)
|
2010-02-25 |
2015-11-24 |
The Johns Hopkins University |
Delivrance prolongee d'agents therapeutiques a un compartiment oculaire
|
|
US20110294730A1
(en)
|
2010-05-31 |
2011-12-01 |
Shantha Totada R |
Method of treating glaucoma and intraocular hypertension
|
|
WO2012021107A2
(fr)
|
2010-08-12 |
2012-02-16 |
Nanyang Technological University |
Formulation de liposomes pour l'administration d'un médicament dans l'œil
|
|
EP2637684A4
(fr)
|
2010-11-08 |
2014-05-07 |
Healor Ltd |
Compositions ophtalmiques tamponnées et leurs procédés d'utilisation
|
|
EP2667875A4
(fr)
|
2011-01-24 |
2014-07-30 |
Inceptum Res & Therapeutics Inc |
Compositions comprenant une prostaglandine pour le traitement de pathologies neuropsychiatriques
|
|
US20130053794A1
(en)
|
2011-08-29 |
2013-02-28 |
Suzanne Cadden |
Sustained release delivery of active agents to treat glaucoma and ocular hypertension
|
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
|
WO2013163219A1
(fr)
|
2012-04-24 |
2013-10-31 |
Allergan, Inc. |
Compositions pharmaceutiques de prostaglandine et de vasoconstricteur, et méthodes les utilisant
|
|
EP2844224B1
(fr)
|
2012-05-03 |
2018-04-11 |
Mati Therapeutics Inc. |
Système d'administration de médicament pour le traitement d'un glaucome à angle ouvert et de l'hypertension oculaire
|
|
JP6408469B2
(ja)
|
2012-09-06 |
2018-10-17 |
ナンヤン テクノロジカル ユニヴァーシティー |
ヒアルロン酸をベースとする薬物送達システム
|
|
JP6298068B2
(ja)
|
2012-10-26 |
2018-03-20 |
フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． |
眼に対する薬物徐放用眼科システム
|
|
US9283231B2
(en)
|
2013-01-31 |
2016-03-15 |
Icon Bioscience, Inc. |
Sustained release formulations for the treatment of intraocular pressure of glaucoma
|
|
AU2013384818A1
(en)
|
2013-03-27 |
2015-11-12 |
Comprehensive Drug Enterprises, Ltd. |
Ophthalmic composition, method for preparing the same, and use of the same
|